Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 10 search results for "based" in Resources. To see all results and access other features, sign up for free.

... — American Cancer Society Squamous Cell Carcinoma of the Bladder: Demographics and Outcomes Associated With Surgery and Radiotherapy — Journal of Surgical Oncology Adenocarcinoma of the Bladder: A Case Report — AME Surgical Journal Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004 ...
Bladder Cancer Survival Rates: By Age, With Treatment, and More
... — American Cancer Society Squamous Cell Carcinoma of the Bladder: Demographics and Outcomes Associated With Surgery and Radiotherapy — Journal of Surgical Oncology Adenocarcinoma of the Bladder: A Case Report — AME Surgical Journal Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004 ...
... Bladder Cancer Stages Show Its SpreadBladder cancer is assigned a stage from 0 to 4 based on the size of the tumor, whether cancer has spread to your lymph nodes (small, bean-shaped organs in the immune system that help fight infections), and whether cancer has spread to other parts of your body. ...
9 Facts About Bladder Cancer
... Bladder Cancer Stages Show Its SpreadBladder cancer is assigned a stage from 0 to 4 based on the size of the tumor, whether cancer has spread to your lymph nodes (small, bean-shaped organs in the immune system that help fight infections), and whether cancer has spread to other parts of your body. ...
... Society Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR) — ClinicoEconomics and Outcomes Research Non Muscle Invasive Bladder Cancer Staging — Cancer Research UK Cancer-Specific Survival of Patients With Non-Muscle-Invasive Bladder Cancer: A Population-Based ...
Non-Muscle-Invasive Bladder Cancer Survival Rates: Which Factors Affect Outlook?
... Society Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR) — ClinicoEconomics and Outcomes Research Non Muscle Invasive Bladder Cancer Staging — Cancer Research UK Cancer-Specific Survival of Patients With Non-Muscle-Invasive Bladder Cancer: A Population-Based ...
... Analysis — Annals of Surgical Urology Identifying Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer Based on Blood Serum Surface-Enhanced Raman Spectroscopy — Biomedical Optics Express Progression — National Cancer Institute What Is Muscle Invasive Bladder Cancer? ...
Non-Muscle-Invasive Bladder Cancer vs. Muscle-Invasive: How They Differ
... Analysis — Annals of Surgical Urology Identifying Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer Based on Blood Serum Surface-Enhanced Raman Spectroscopy — Biomedical Optics Express Progression — National Cancer Institute What Is Muscle Invasive Bladder Cancer? ...
... bladder).Additionally, Keytruda Qlex may be combined with enfortumab vedotin for adults with locally advanced or metastatic urothelial cancer.Keytruda Qlex can also be given on its own for: People with locally advanced or metastatic urothelial carcinoma who aren’t eligible for cisplatin chemotherapy Those whose disease worsened during or after platinum-based ...
Keytruda in 60 Seconds: FDA Approves Injection for Bladder Cancer
... bladder).Additionally, Keytruda Qlex may be combined with enfortumab vedotin for adults with locally advanced or metastatic urothelial cancer.Keytruda Qlex can also be given on its own for: People with locally advanced or metastatic urothelial carcinoma who aren’t eligible for cisplatin chemotherapy Those whose disease worsened during or after platinum-based ...
... Bladder Cancer Chemotherapy — Bladder Cancer Advocacy Network Treatment Matrix: Systemic Chemotherapy — Bladder Cancer Advocacy Network Chemotherapy for Metastatic Bladder Cancer — Cancer Research UK Radiation Therapy for Bladder Cancer — American Cancer Society Trimodal Therapy for Bladder Cancer — Cancer Council NSW Treatment of Bladder Cancer, Based ...
Chemo for Bladder Cancer: 7 Things To Expect
... Bladder Cancer Chemotherapy — Bladder Cancer Advocacy Network Treatment Matrix: Systemic Chemotherapy — Bladder Cancer Advocacy Network Chemotherapy for Metastatic Bladder Cancer — Cancer Research UK Radiation Therapy for Bladder Cancer — American Cancer Society Trimodal Therapy for Bladder Cancer — Cancer Council NSW Treatment of Bladder Cancer, Based ...
... Cancer Diagnosis — National Cancer Institute Bladder Cancer — Mayo Clinic Lynch Syndrome: Its Impact on Urothelial Carcinoma — International Journal of Molecular Sciences Lynch Syndrome — MedlinePlus Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline — American Urological Association Treatment of Bladder Cancer, Based ...
What To Expect With Urothelial Carcinoma: Symptoms and Treatment Options
... Cancer Diagnosis — National Cancer Institute Bladder Cancer — Mayo Clinic Lynch Syndrome: Its Impact on Urothelial Carcinoma — International Journal of Molecular Sciences Lynch Syndrome — MedlinePlus Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline — American Urological Association Treatment of Bladder Cancer, Based ...
... These treatments target any remaining cancer cells and help prevent new tumors from forming.Your doctor will recommend a treatment plan based on the type, size, and grade of your tumor. Some people get maintenance therapy for one to three years to keep the cancer from returning. ...
What Is TURBT? Key Facts About Bladder Tumor Removal
... These treatments target any remaining cancer cells and help prevent new tumors from forming.Your doctor will recommend a treatment plan based on the type, size, and grade of your tumor. Some people get maintenance therapy for one to three years to keep the cancer from returning. ...
... Before bladder surgery, the usual chemotherapy is a cisplatin-based combination, most often gemcitabine and cisplatin or dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin. ...
MIBC Treatment Options: Surgery, Chemotherapy, and Immunotherapy
... Before bladder surgery, the usual chemotherapy is a cisplatin-based combination, most often gemcitabine and cisplatin or dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin. ...
... Decision-Making for Patients With Bladder Cancer — Urology Times Treatment of Primary Non-Muscle Invasive Urothelial Carcinoma of the Bladder — Wolters Kluwer UpToDate TURBT: Transurethral Resection of Bladder Tumor — Cleveland Clinic Bladder Cancer Treatment (PDQ) — Health Professional Version — National Cancer Institute Treatment of Bladder Cancer, Based ...
7 Treatments for Non-Muscle-Invasive Bladder Cancer: What To Consider
... Decision-Making for Patients With Bladder Cancer — Urology Times Treatment of Primary Non-Muscle Invasive Urothelial Carcinoma of the Bladder — Wolters Kluwer UpToDate TURBT: Transurethral Resection of Bladder Tumor — Cleveland Clinic Bladder Cancer Treatment (PDQ) — Health Professional Version — National Cancer Institute Treatment of Bladder Cancer, Based ...